Skip to main content
Patient Protect circular logo mark in purple and white used for site navigationPatient Protect

HIPAA compliance for GLP-1 clinics in District of Columbia

District of Columbia keeps obligations of its own alongside HIPAA, with different recipients and triggers from the federal rules. Patient Protect has not recorded any District of Columbia rule that applies to GLP-1 clinics differently from other providers in the state — the statewide rules below are the ones that reach you.

District of Columbia jurisdiction record verified against primary state authority November 2026. General reference, not legal advice.

Does this reach your practice?

Two questions have to be settled before any state rule matters: whether HIPAA reaches a practice like yours, and whether District of Columbia's own law reaches a practice that HIPAA already covers.

Federal — is this practice a covered entity

“Wellness platform” is a marketing label, not a legal classification. Map the consumer brand, clinical entity, prescribers, management company, pharmacies, laboratories, and technology vendors; then determine which entity conducts an adopted transaction, acts as a Business Associate, or falls outside HIPAA. Every covered entity and Business Associate in the chain must perform its applicable duties below.

State — how District of Columbia law interacts with HIPAA

District of Columbia substitutes federal notice for part of its scheme but keeps a residual state duty of its own. GLP-1 clinics operating here should expect both a federal and a state obligation, with different recipients and triggers.

DC uses a New-York-style split: HIPAA-compliant individual-notice is deemed compliant for the § 28-3852 individual-notice obligation (§ 28-3852(g)), but the separate DC Attorney General notification obligation under § 28-3852(b-1) applies independently once the 50-resident threshold is met.

What District of Columbia adds for GLP-1 clinics specifically

Rules that exist because of the combination — not federal HIPAA, which applies the same way everywhere, and not District of Columbia's general breach law, which applies the same way to every business in the state.

No verified intersection rules recorded

Patient Protect has not recorded any District of Columbia rule that applies to GLP-1 clinics differently from any other practice in the state. Where that is the case, the federal obligations and the District of Columbia rules below are the whole picture, and the glp-1 clinics guidance that applies nationally is the better starting point.

HIPAA compliance for GLP-1 clinics→

District of Columbia breach obligations

These apply to businesses generally rather than to GLP-1 clinics in particular, and they are shown after applicability because whether they reach you depends on the answer above.

District of Columbiabreach data →

Individual notice deadline

In the most expedient time possible and without unreasonable delay, subject to the needs of law enforcement and any measures necessary to determine the scope of the breach and restore the reasonable integrity of the data system.

The statute does not fix a numeric outer bound. Unreasonable delay is itself a violation and may result in state enforcement action, so treat the operative timeframe as the shortest window your incident circumstances reasonably support.

State regulator notice

Required at 50+ residents

The person or entity must notify the District of Columbia Attorney General in writing when a breach affects 50 or more District residents.

Source: D.C. Code § 28-3852(a)

How we checked this law
  • : Checked against the D.C. Council's official Code of the District of Columbia, current through November 3, 2026 (last codified D.C. Law 26-190, effective October 14, 2026). D.C. Code § 28-3852 was last amended by D.C. Law 23-98, effective June 17, 2020. No later amendment or future effective date was found.

What applies to GLP-1 clinics everywhere

Calling the operation a wellness platform does not change the healthcare activity occurring underneath it. GLP-1 businesses must map the legal and data relationship among the consumer brand, clinical entity, prescriber network, telehealth platform, laboratories, pharmacies, marketers, and technology vendors.

The complete patient journey from advertisement and eligibility screening through intake, clinical evaluation, prescribing, fulfillment, monitoring, and discontinuation
Online intake, health questionnaires, identity verification, consent, EHR, telehealth, and scheduling systems
E-prescribing, laboratory ordering and results, pharmacy communication, fulfillment, and adverse-event workflows
Weight, photographs, biometrics, medication history, payment information, messages, and progress data
Email, text, patient support, coaching, refill, and asynchronous clinical communication
Affiliate, influencer, advertising, analytics, lead-generation, and tracking technologies that receive health-related information
Full glp-1 clinicscompliance guide →

Federal obligations still have to be evidenced for GLP-1 clinics in District of Columbia.

The risk assessment asks what your practice actually does — which systems hold records, who reaches them, which vendors touch them — and reports against the obligations that apply to you, including the District of Columbia rules on this page.

Start the risk assessment